FDA Issues: New Drug Approval, Regulatory Issues
 New HIV Drug Dolutegravir Could Soon Be Approved by FDA (February 28, 2013)
From TheBodyPRO.com
 What's a Fulyzaq? I Thought You'd Never Ask (January 3, 2013)
From Journal Watch
On TheBodyPRO.com
- FDA Approval of Generic ARVs (November/December 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Food and Drug Administration Urged to Speed Approval of Drugs (September 26, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Approval of Generic ARVs (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- How HIV Drugs Get Approved (August 9, 2012)
To read PDF, click here.
From AIDS InfoNet
- More Than 150 Antiretroviral Drugs Available Through PEPFAR for Worldwide HIV/AIDS Relief (July 23, 2012)
From U.S. Food and Drug Administration
- The FDA Gives Truvada as PreP the Official Okay (July 17, 2012)
In Housing Works AIDS Issues Update, from Housing Works
- Advocates, Policy Experts Respond to FDA Approval of Truvada for HIV Prevention (July 17, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 Truvada Approved to Reduce the Risk of Sexually Transmitted HIV in People Who Are Not Infected With the Virus (July 16, 2012)
From U.S. Food and Drug Administration
 OraQuick In-Home HIV Test: Another Tool in the Toolbox (July 13, 2012)
In AIDS United Policy Update, from AIDS United
- New In-Home HIV Test Raises Follow-Up Concerns (July 6, 2012)
In Kaiser Daily Health Policy Report, from Henry J. Kaiser Family Foundation
- FDA Approves at-Home HIV Test, Available in October (July 5, 2012)
In Kaiser Daily Health Policy Report, from Henry J. Kaiser Family Foundation
- Independent Testing for Independence Day: FDA Approves Over-the-Counter Oral HIV Test (July 3, 2012)
In Housing Works AIDS Issues Update, from Housing Works
- First In-Home, Rapid HIV Antibody Test Approved for Use in U.S. (July 3, 2012)
From U.S. Food and Drug Administration
- FDA Approval of Generic ARVs: Nevirapine and Combivir Now Off-Patent in the U.S. (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Fosamprenavir Pediatric Dosing Approved in U.S. for Ages 4 Weeks to <6 Years (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
 FDA Delays Decision on Drug to Prevent HIV Infection (June 11, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Massachusetts: Promotion for Vertex Drug Would Mislead, FDA Says (June 4, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 What the OraQuick In-Home HIV Test Means for HIV Treatment and Prevention: A Panel Discussion (May 25, 2012)
From AIDS United
- FDA Approves Generic Formulations of Lamivudine and Zidovudine Tablets and Nevirapine Tablets and Oral Suspension (May 25, 2012)
From U.S. Food and Drug Administration
|
Advertisement
|
Email
Glossary
